Staging of Breast Cancer with 18F-FDG PET and PET/CT

被引:0
作者
Aukema, Tjeerd S. [1 ]
Rutgers, Emiel J. T. [2 ]
Vogel, Wouter V. [1 ]
Olmos, Renato A. Valdes [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Nucl Med, NL-1066 CX Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg, NL-1066 CX Amsterdam, Netherlands
关键词
POSITRON-EMISSION-TOMOGRAPHY; SENTINEL-NODE BIOPSY; BROWN ADIPOSE-TISSUE; FDG-PET; SUSPECTED RECURRENCE; COMPUTED-TOMOGRAPHY; INTEGRATED PET/CT; BONE METASTASES; FOLLOW-UP; USA-FAT;
D O I
10.2174/157340509790112871
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has been recognised as a sensitive tool for the staging of various malignancies, such as lung carcinoma, lymphoma, and esophageal cancer. Its role in staging process of breast cancer however is subject to discussion, mainly due to supposedly lower metabolic activity of the disease. In this article, we discuss the current literature on FDG PET/CT for the staging of breast cancer, including staging of the primary tumour and the axilla, and the detection of distant metastases both in primary and recurrent breast cancer. In addition, we will focus on several methodological aspects and acquisition protocols to optimize the imaging of breast cancer patients by FDG PET/CT.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 50 条
  • [1] 18F-FDG PET/CT for Staging and Restaging of Breast Cancer
    Groheux, David
    Cochet, Alexandre
    Humbert, Olivier
    Alberini, Jean-Louis
    Hindie, Elif
    Mankoff, David
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 17S - 26S
  • [2] 18F-FDG PET/CT in the Staging and Management of Breast Cancer
    Garcia, J. R.
    Perez, Cristina
    Bassa, Pere
    Capdevila, Laia
    Ramos, Francisco
    Valenti, Vicens
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 191 - 192
  • [3] The value of 18F-FDG PET/CT imaging in breast cancer staging
    Yararbas, Ulkem
    Avci, Neslihan Cetin
    Yeniay, Levent
    Argon, Aziz Murat
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 18 (01) : 72 - 79
  • [4] Gallbladder cancer staging with 18F-FDG PET-CT
    Ramos-Font, C.
    Santiago Chinchilla, A.
    Rodriguez-Fernandez, A.
    Rebollo Aguirre, A. C.
    Gomez Rio, M.
    Llamas Elvira, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2009, 28 (02): : 74 - 77
  • [5] 18F-FDG PET/CT Imaging In Oncology
    Almuhaideb, Ahmad
    Papathanasiou, Nikolaos
    Bomanji, Jamshed
    ANNALS OF SAUDI MEDICINE, 2011, 31 (01) : 3 - 13
  • [6] Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer
    Roop, Mohan J.
    Singh, Baljinder
    Singh, Harmandeep
    Watts, Ankit
    Kohli, Pavneet S.
    Mittal, Bhagwant R.
    Singh, Gurpreet
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) : 335 - 340
  • [7] Clinical impact of 18F-FDG PET/CT on initial staging and therapy planning for breast cancer
    Gunalp, Bengul
    Ince, Semra
    Karacalioglu, Alper Ozgur
    Ayan, Asli
    Emer, Ozdes
    Alagoz, Engin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (04) : 693 - 698
  • [8] Preoperative Axillary Staging Using 18F-FDG PET/CT and Ultrasonography in Breast Cancer Patients
    Kim, Yong Hun
    Lee, Jin Sun
    Lee, Chul Joo
    Kim, Je Ryong
    Chang, Eil Sung
    JOURNAL OF BREAST CANCER, 2009, 12 (03) : 163 - 169
  • [9] Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MR Imaging and 18F-FDG PET/CT
    Heusch, Philipp
    Buchbender, Christian
    Koehler, Jens
    Nensa, Felix
    Gauler, Thomas
    Gomez, Benedikt
    Reiss, Henning
    Stamatis, Georgios
    Kuehl, Hilmar
    Hartung, Verena
    Heusner, Till A.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (03) : 373 - 378
  • [10] 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men
    Ulaner, Gary A.
    Juarez, Jessica
    Riedl, Christopher C.
    Goldman, Debra A.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (04) : 472 - 477